LON:UPR Uniphar (UPR) Share Price, News & Analysis GBX 230 -4.00 (-1.71%) As of 11:01 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesBuy This Stock About Uniphar Stock (LON:UPR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Uniphar alerts:Sign Up Key Stats Today's Range 230▼ 239.5050-Day Range 197▼ 23752-Week Range 163▼ 240Volume31,511 shsAverage Volume30,826 shsMarket Capitalization£715.95 millionP/E Ratio15.99Dividend Yield0.87%Price TargetGBX 310Consensus RatingBuy Company OverviewHeadquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.Read More… Uniphar Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks53rd Percentile Overall ScoreUPR MarketRank™: Uniphar scored higher than 53% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingUniphar has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageUniphar has only been the subject of 1 research reports in the past 90 days.Read more about Uniphar's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Uniphar is 15.99, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.66.Price to Earnings Ratio vs. SectorThe P/E ratio of Uniphar is 15.99, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 22.18.Price to Book Value per Share RatioUniphar has a P/B Ratio of 1.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for UPR. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldUniphar has a dividend yield of 0.77%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthUniphar does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Uniphar is 13.91%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Uniphar's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for UPR. News and Social Media2.0 / 5News SentimentN/A News SentimentUniphar has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Uniphar this week, compared to 0 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Uniphar insiders have not sold or bought any company stock.Percentage Held by Insiders10.07% of the stock of Uniphar is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions45.25% of the stock of Uniphar is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Uniphar's insider trading history. Receive UPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Uniphar and its competitors with MarketBeat's FREE daily newsletter. Email Address UPR Stock News HeadlinesUniphar PLC (UPR) Gets a Buy from RBC CapitalMarch 22, 2025 | markets.businessinsider.comUniphar And Two Other Promising Penny Stocks To WatchFebruary 24, 2025 | finance.yahoo.comThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside and write a book about it. This isn't just another Bitcoin prediction – it's a complete roadmap for what I believe will be the biggest wealth-building opportunity of this decade. The evidence is so compelling, I'm doing something that probably seems insane: I'm giving away my entire book for free. April 24, 2025 | Crypto 101 Media (Ad)Uncovering Opportunities: 3 Penny Stocks With Market Caps Under US$500MJanuary 22, 2025 | finance.yahoo.comUniphar plc (UPR.IR)October 17, 2024 | finance.yahoo.comUniphar says on track to meet expectations for gross profit for 2024August 1, 2024 | lse.co.ukUniphar ups full-year dividend as profit falls but revenue climbsFebruary 27, 2024 | lse.co.ukUniphar PLC UPRFebruary 17, 2024 | morningstar.comSee More Headlines UPR Stock Analysis - Frequently Asked Questions How have UPR shares performed this year? Uniphar's stock was trading at GBX 170.80 at the start of the year. Since then, UPR stock has increased by 34.7% and is now trading at GBX 230. View the best growth stocks for 2025 here. How do I buy shares of Uniphar? Shares of UPR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Uniphar own? Based on aggregate information from My MarketBeat watchlists, some other companies that Uniphar investors own include IXICO (IXI) and ANGLE (AGL). Company Calendar Today4/24/2025Record date for 5/16 Dividend4/24/2025Ex-Dividend for 5/16 Dividend4/24/2025Dividend Payable5/16/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Distribution Sub-IndustryN/A Current SymbolLON:UPR CIKN/A Webwww.uniphar.ie Phone353 1 428 7777FaxN/AEmployees3,000Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 310 High Stock Price TargetGBX 310 Low Stock Price TargetGBX 310 Potential Upside/Downside+34.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 14.38 Trailing P/E Ratio15.99 Forward P/E Ratio12.22 P/E GrowthN/ANet Income£51.04 million Net Margins1.68% Pretax MarginN/A Return on Equity13.18% Return on Assets3.76% Debt Debt-to-Equity Ratio119.48 Current Ratio0.90 Quick Ratio0.60 Sales & Book Value Annual Sales£3.03 billion Price / Sales0.24 Cash FlowGBX 23.08 per share Price / Cash Flow9.97 Book ValueGBX 127.58 per share Price / Book1.80Miscellaneous Outstanding Shares311,281,806Free FloatN/AMarket Cap£715.95 million OptionableNot Optionable Beta0.75 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (LON:UPR) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Uniphar plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Uniphar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.